載入...
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...
Na minha lista:
| 發表在: | J Basic Clin Pharm |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910469/ https://ncbi.nlm.nih.gov/pubmed/27330257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.183260 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|